Following discussions with Community Pharmacy Scotland, the Scottish government has agreed to a six per cent rise in the global fund allocation for community
pharmacies in 2023-24, bringing the total remuneration to approximately £219.5 million.
A finalised agreement has been reached with Community Pharmacy Scotland for a one-year funding package for the financial year 2023-24, as stated in a Scottish
government circular distributed to community pharmacy contractors and NHS Boards on August 4.
The circular said this settlement will lead to the most substantial increment ever approved for the community pharmacy network.
"The global sum remuneration will be £219.533 million, signifying a 6 per cent increase from the previous year and setting the groundwork for 2024/25," stated
Professor Alison Strath, Chief Pharmaceutical Officer for Scotland, in the document. "The guaranteed income from the drug tariff will remain at £80 million for
the financial year, without yearly changes."